Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): A trial of the Eastern cooperative oncology group
Glenn Liu, Yu Hui Chen, Robert Dipaola, Michael Carducci, George Wilding
Research output: Contribution to journal › Article › peer-review
20Scopus
citations
Fingerprint
Dive into the research topics of 'Phase II trial of weekly ixabepilone in men with metastatic castrate-resistant prostate cancer (E3803): A trial of the Eastern cooperative oncology group'. Together they form a unique fingerprint.